COVID-19 Diagnostics Market Report by Product Type (Reagents and Kits, Instruments, and Others), Sample Type (Nasopharyngeal Swabs, Oropharyngeal Swabs, Nasal Swabs, Blood, and Others), Test Type (Molecular (RT-PCR) Testing, Antigen-based Testing, Antibody (Serology) Testing, and Others), Mode (Point-of-Care (PoC), Non-Point-of-Care (Non-PoC)), End Use (Laboratories, Hospitals, Diagnostic Centers and Clinics, and Others), and Region 2024-2032

COVID-19 Diagnostics Market Report by Product Type (Reagents and Kits, Instruments, and Others), Sample Type (Nasopharyngeal Swabs, Oropharyngeal Swabs, Nasal Swabs, Blood, and Others), Test Type (Molecular (RT-PCR) Testing, Antigen-based Testing, Antibody (Serology) Testing, and Others), Mode (Point-of-Care (PoC), Non-Point-of-Care (Non-PoC)), End Use (Laboratories, Hospitals, Diagnostic Centers and Clinics, and Others), and Region 2024-2032

Report Format: PDF+Excel | Report ID: SR112024A3552
Buy Now

1   Preface
2   Scope and Methodology
    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction
    4.1    Overview
    4.2    Key Industry Trends
5   Global COVID-19 Diagnostics Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Product Type
    6.1    Reagents and Kits
        6.1.1 Market Trends and Forecast
    6.2    Instruments
        6.2.1 Market Trends and Forecast
    6.3    Others
        6.3.1 Market Trends and Forecast
7   Market Breakup by Sample Type
    7.1    Nasopharyngeal Swabs
        7.1.1 Market Trends and Forecast
    7.2    Oropharyngeal Swabs
        7.2.1 Market Trends and Forecast
    7.3    Nasal Swabs
        7.3.1 Market Trends and Forecast
    7.4    Blood
        7.4.1 Market Trends and Forecast
    7.5    Others
        7.5.1 Market Trends and Forecast
8   Market Breakup by Test Type
    8.1    Molecular (RT-PCR) Testing
        8.1.1 Market Trends and Forecast
    8.2    Antigen-based Testing
        8.2.1 Market Trends and Forecast
    8.3    Antibody (Serology) Testing
        8.3.1 Market Trends and Forecast
    8.4    Others
        8.4.1 Market Trends and Forecast
9   Market Breakup by Mode
    9.1    Point-of-Care (PoC)
        9.1.1 Market Trends and Forecast
    9.2    Non-Point-of-Care (Non-PoC)
        9.2.1 Market Trends and Forecast
10  Market Breakup by End Use
    10.1    Laboratories
        10.1.1 Market Trends and Forecast
    10.2    Hospitals
        10.2.1 Market Trends and Forecast
    10.3    Diagnostic Centers and Clinics
        10.3.1 Market Trends and Forecast
    10.4    Others
        10.4.1 Market Trends and Forecast
11  Market Breakup by Region
    11.1    North America
        11.1.1 United States
           11.1.1.1 Market Trends and Forecast
        11.1.2 Canada
           11.1.2.1 Market Trends and Forecast
    11.2    Asia-Pacific
        11.2.1 China
           11.2.1.1 Market Trends and Forecast
        11.2.2 Japan
           11.2.2.1 Market Trends and Forecast
        11.2.3 India
           11.2.3.1 Market Trends and Forecast
        11.2.4 South Korea
           11.2.4.1 Market Trends and Forecast
        11.2.5 Australia
           11.2.5.1 Market Trends and Forecast
        11.2.6 Indonesia
           11.2.6.1 Market Trends and Forecast
        11.2.7 Others
           11.2.7.1 Market Trends and Forecast
    11.3    Europe
        11.3.1 Germany
           11.3.1.1 Market Trends and Forecast
        11.3.2 France
           11.3.2.1 Market Trends and Forecast
        11.3.3 United Kingdom
           11.3.3.1 Market Trends and Forecast
        11.3.4 Italy
           11.3.4.1 Market Trends and Forecast
        11.3.5 Spain
           11.3.5.1 Market Trends and Forecast
        11.3.6 Russia
           11.3.6.1 Market Trends and Forecast
        11.3.7 Others
           11.3.7.1 Market Trends and Forecast
    11.4    Latin America
        11.4.1 Brazil
           11.4.1.1 Market Trends and Forecast
        11.4.2 Mexico
           11.4.2.1 Market Trends and Forecast
        11.4.3 Others
           11.4.3.1 Market Trends and Forecast
    11.5    Middle East and Africa
        11.5.1 Market Trends and Forecast
        11.5.2 Market Breakup by Country
12  SWOT Analysis
    12.1    Overview
    12.2    Strengths
    12.3    Weaknesses
    12.4    Opportunities
    12.5    Threats
13  Value Chain Analysis
14  Porters Five Forces Analysis
    14.1    Overview
    14.2    Bargaining Power of Buyers
    14.3    Bargaining Power of Suppliers
    14.4    Degree of Competition
    14.5    Threat of New Entrants
    14.6    Threat of Substitutes
15  Price Analysis
16  Competitive Landscape
    16.1    Market Structure
    16.2    Key Players
    16.3    Profiles of Key Players
        16.3.1    Abbott Laboratories
           16.3.1.1 Company Overview
           16.3.1.2 Product Portfolio
           16.3.1.3 Financials
           16.3.1.4 SWOT Analysis
        16.3.2    Becton Dickinson and Company
           16.3.2.1 Company Overview
           16.3.2.2 Product Portfolio
           16.3.2.3 Financials
           16.3.2.4 SWOT Analysis
        16.3.3    bioMérieux SA
           16.3.3.1 Company Overview
           16.3.3.2 Product Portfolio
           16.3.3.3 Financials
           16.3.3.4 SWOT Analysis
        16.3.4    Bio-Rad Laboratories
           16.3.4.1 Company Overview
           16.3.4.2 Product Portfolio
           16.3.4.3 Financials
           16.3.4.4 SWOT Analysis
        16.3.5    Danaher Corporation
           16.3.5.1 Company Overview
           16.3.5.2 Product Portfolio
           16.3.5.3 Financials
           16.3.5.4 SWOT Analysis
        16.3.6    F. Hoffman-La Roche Ltd. (Roche Holding AG)
           16.3.6.1 Company Overview
           16.3.6.2 Product Portfolio
           16.3.6.3 Financials
        16.3.7    Luminex Corporation
           16.3.7.1 Company Overview
           16.3.7.2 Product Portfolio
           16.3.7.3 Financials
           16.3.7.4 SWOT Analysis
        16.3.8    PerkinElmer Inc.
           16.3.8.1 Company Overview
           16.3.8.2 Product Portfolio
           16.3.8.3 Financials
           16.3.8.4 SWOT Analysis
        16.3.9    Quest Diagnostics Incorporated
           16.3.9.1 Company Overview
           16.3.9.2 Product Portfolio
           16.3.9.3 Financials
           16.3.9.4 SWOT Analysis
        16.3.10    Robert Bosch GmbH
           16.3.10.1 Company Overview
           16.3.10.2 Product Portfolio
        16.3.11    Seegene Inc.
           16.3.11.1 Company Overview
           16.3.11.2 Product Portfolio
           16.3.11.3 Financials
        16.3.12    Siemens Aktiengesellschaft
           16.3.12.1 Company Overview
           16.3.12.2 Product Portfolio
           16.3.12.3 Financials
           16.3.12.4 SWOT Analysis
        16.3.13    Thermo Fisher Scientific Inc.
           16.3.13.1 Company Overview
           16.3.13.2 Product Portfolio
           16.3.13.3 Financials
           16.3.13.4 SWOT Analysis

List of Figures

Figure 1: Global: COVID-19 Diagnostics Market: Major Drivers and Challenges
Figure 2: Global: COVID-19 Diagnostics Market: Sales Value (in Billion US$), 2024-2032
Figure 3: Global: COVID-19 Diagnostics Market: Breakup by Product Type (in %), 2023
Figure 4: Global: COVID-19 Diagnostics Market: Breakup by Sample Type (in %), 2023
Figure 5: Global: COVID-19 Diagnostics Market: Breakup by Test Type (in %), 2023
Figure 6: Global: COVID-19 Diagnostics Market: Breakup by Mode (in %), 2023
Figure 7: Global: COVID-19 Diagnostics Market: Breakup by End Use (in %), 2023
Figure 8: Global: COVID-19 Diagnostics Market: Breakup by Region (in %), 2023
Figure 9: Global: COVID-19 Diagnostics (Reagents and Kits) Market: Sales Value (in Million US$), 2024-2032
Figure 10: Global: COVID-19 Diagnostics (Instruments) Market: Sales Value (in Million US$), 2024-2032
Figure 11: Global: COVID-19 Diagnostics (Other Product Types) Market: Sales Value (in Million US$), 2024-2032
Figure 12: Global: COVID-19 Diagnostics (Nasopharyngeal Swabs) Market: Sales Value (in Million US$), 2024-2032
Figure 13: Global: COVID-19 Diagnostics (Oropharyngeal Swabs) Market: Sales Value (in Million US$), 2024-2032
Figure 14: Global: COVID-19 Diagnostics (Nasal Swabs) Market: Sales Value (in Million US$), 2024-2032
Figure 15: Global: COVID-19 Diagnostics (Blood) Market: Sales Value (in Million US$), 2024-2032
Figure 16: Global: COVID-19 Diagnostics (Other Sample Types) Market: Sales Value (in Million US$), 2024-2032
Figure 17: Global: COVID-19 Diagnostics (Molecular/RT-PCR Testing) Market: Sales Value (in Million US$), 2024-2032
Figure 18: Global: COVID-19 Diagnostics (Antigen-based Testing) Market: Sales Value (in Million US$), 2024-2032
Figure 19: Global: COVID-19 Diagnostics (Antibody-Testing- Serology) Market: Sales Value (in Million US$), 2024-2032
Figure 20: Global: COVID-19 Diagnostics (Other Test Types) Market: Sales Value (in Million US$), 2024-2032
Figure 21: Global: COVID-19 Diagnostics (Point-of-Care - PoC) Market: Sales Value (in Million US$), 2024-2032
Figure 22: Global: COVID-19 Diagnostics (Non-Point-of-Care - Non-PoC) Market: Sales Value (in Million US$), 2024-2032
Figure 23: Global: COVID-19 Diagnostics (Laboratories) Market: Sales Value (in Million US$), 2024-2032
Figure 24: Global: COVID-19 Diagnostics (Hospitals) Market: Sales Value (in Million US$), 2024-2032
Figure 25: Global: COVID-19 Diagnostics (Diagnostic Centers and Clinics) Market: Sales Value (in Million US$), 2024-2032
Figure 26: Global: COVID-19 Diagnostics (Other End Uses) Market: Sales Value (in Million US$), 2024-2032
Figure 27: North America: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2024-2032
Figure 28: United States: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2024-2032
Figure 29: Canada: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2024-2032
Figure 30: Asia-Pacific: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2024-2032
Figure 31: China: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2024-2032
Figure 32: Japan: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2024-2032
Figure 33: India: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2024-2032
Figure 34: South Korea: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2024-2032
Figure 35: Australia: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2024-2032
Figure 36: Indonesia: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2024-2032
Figure 37: Others: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2024-2032
Figure 38: Europe: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2024-2032
Figure 39: Germany: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2024-2032
Figure 40: France: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2024-2032
Figure 41: United Kingdom: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2024-2032
Figure 42: Italy: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2024-2032
Figure 43: Spain: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2024-2032
Figure 44: Russia: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2024-2032
Figure 45: Others: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2024-2032
Figure 46: Latin America: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2024-2032
Figure 47: Brazil: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2024-2032
Figure 48: Mexico: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2024-2032
Figure 49: Others: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2024-2032
Figure 50: Middle East and Africa: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2024-2032
Figure 51: Middle East and Africa: COVID-19 Diagnostics Market: Breakup by Country (in %), 2023
Figure 52: Global: COVID-19 Diagnostics Industry: SWOT Analysis
Figure 53: Global: COVID-19 Diagnostics Industry: Value Chain Analysis
Figure 54: Global: COVID-19 Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: COVID-19 Diagnostics Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: COVID-19 Diagnostics Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
Table 3: Global: COVID-19 Diagnostics Market Forecast: Breakup by Sample Type (in Million US$), 2024-2032
Table 4: Global: COVID-19 Diagnostics Market Forecast: Breakup by Test Type (in Million US$), 2024-2032
Table 5: Global: COVID-19 Diagnostics Market Forecast: Breakup by Mode (in Million US$), 2024-2032
Table 6: Global: COVID-19 Diagnostics Market Forecast: Breakup by End Use (in Million US$), 2024-2032
Table 7: Global: COVID-19 Diagnostics Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 8: Global: COVID-19 Diagnostics Market: Competitive Structure
Table 9: Global: COVID-19 Diagnostics Market: Key Players

COVID-19 Diagnostics Market Report by Product Type (Reagents and Kits, Instruments, and Others), Sample Type (Nasopharyngeal Swabs, Oropharyngeal Swabs, Nasal Swabs, Blood, and Others), Test Type (Molecular (RT-PCR) Testing, Antigen-based Testing, Antibody (Serology) Testing, and Others), Mode (Point-of-Care (PoC), Non-Point-of-Care (Non-PoC)), End Use (Laboratories, Hospitals, Diagnostic Centers and Clinics, and Others), and Region 2024-2032
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More